-
02:17:35 PM

SEPSF Stock News

08/02/23 1:32 PM
OTC : SEPSF
Asep Inc. Obtains Exclusive Worldwide License from the University of British Columbia for Ground-breaking Medical Device Coating Technology
VANCOUVER, BC, July 31, 2023/ PRNewswire/- Asep Medical Holdings Inc. is pleased to announce that, as of July 21, 2023, it has completed the final milestone in its acquisition of SafeCoat Medical Inc. and entered into an exclusive worldwide license agreement with the University of British Columbia, through its subsidiary SafeCoat, for the use, development and...
RHEA-AI
neutral
07/14/23 7:00 PM
OTC : SEPSF
covid-19
Another Breakthrough-- Asep Inc.';s A.I.-Based Sepsis Technology Identifies COVID-19 Severity from a Blood Sample
A recent study led by Asep Inc.' s Founder, Chair and CEO, Dr. Robert E. W. Hancock, concludes that there is hope for improved clinical management of COVID-19 patients by better assessing the severity of sepsis, a deadly disease that impacts many COVID-19 patients. VANCOUVER, BC, July 14, 2023/ PRNewswire/- Asep Medical Holdings Inc. is pleased to announce the results of a...
RHEA-AI
neutral
06/23/23 7:00 PM
OTC : SEPSF
Asep Inc. Receives Grant from NanoMedicines Innovation Network (NMIN), Funded by the Government of Canada
VANCOUVER, BC, June 23, 2023/ PRNewswire/- Asep Medical Holdings Inc. is pleased to announce, along with their academic partners at the University of British Columbia, that they have been awarded a grant from the NanoMedicines Innovation Network to investigate further and identify an optimal nanoparticle-peptide solution with the specific goal of treating...
RHEA-AI
very positive
06/20/23 7:00 AM
OTC : SEPSF
Asep Inc. Founder, Chair and CEO, Dr. Robert E. W. Hancock, Ranked 4th Best Microbiologist in the World
VANCOUVER, BC, June 20, 2023/ PRNewswire/- Asep Medical Holdings Inc. is delighted to announce that the Company's Founder, Chair and CEO has recently been ranked as the 4 th Best Microbiologist in the World according to www.research.com, a leading scientific research portal based in Southampton, England. Hancock was also installed as a Fellow of the National...
RHEA-AI
positive
06/09/23 7:00 PM
OTC : SEPSF
Asep Inc. Signs Definitive Agreement for Joint Venture with Bahrain-based Seaspring W.L.L. for Regulatory Approval and Commercialization of Sepsis Diagnosis Technology in the Kingdom of Bahrain, the Middle East and North Africa
VANCOUVER, BC, June 9, 2023/ PRNewswire/- Pursuant to the signing of a Letter of Intent in December 2022, Asep Medical Holdings Inc. is delighted to announce it has signed a definitive agreement for a joint venture with Bahrain- based international investment consultancy firm, Seaspring W.L.L., to advance regulatory approval and commercialization of the...
RHEA-AI
positive
06/02/23 7:00 PM
OTC : SEPSF
Asep Inc. Announces Ground-breaking A.I. Technology for Rapid Identification of Severe Sepsis and Improved Superbug Therapies
VANCOUVER, BC, June 2, 2023/ PRNewswire/- Asep Medical Holdings Inc. announces the ground-breaking use of artificial intelligence to rapidly identify infections at increased risk of severe sepsis. Hancock, Killam Professor at the University of British Columbia, and analyzes the dysfunctional immune responses involved in sepsis to identify sets of genes...
RHEA-AI
neutral
01/27/23 7:00 PM
OTC : SEPSF
Asep Inc. Signs Joint Venture Term Sheet with Leading Chinese Medical Diagnostic Company Sansure Biotech Inc. in Preparation for the Commercialization of the Sepset(ER) Sepsis Diagnostic Test in China
The deal highlights the growing global interest in Asep Inc.' s early sepsis diagnostic, developed using artificial intelligence, which has proven highly accurate in clinical studies to date and is projected to save lives, significantly impact hospitals' bottom line, and reduce antibiotic usage in non-sepsis patients thus preventing antibiotic...
RHEA-AI
neutral